Tumour stimulation by anti-oestrogens-Reference-Cited by-同舟云学术

Tumour stimulation by anti-oestrogens

Published:1977-12 Issue:12 Volume:64 Page:900-901
ISSN:0007-1323
Container-title:British Journal of Surgery
language:en
Short-container-title:

Author:

McIntosh I H¹,Thynne G S¹

Affiliation:

1. Breast Unit, Royal Marsden Hospital, London

Abstract

Abstract Two women who developed tumour progression while taking anti-oestrogens are described and some of the possible mechanisms for this action are discussed.

Funder

Eranda Trust

Publisher

Oxford University Press (OUP)

Subject

Surgery

Link

http://academic.oup.com/bjs/article-pdf/64/12/900/37052063/bjs1800641218.pdf

Reference13 articles.

1. Antioestrogens in the treatment of breast cancer: value of nafoxidine in 52 advanced cases;Bloom;Br. Med. J.,1974

2. Antioestrogens and breast cancer treatment;Carbone;Ann. Intern. Med.,1975

3. A new antioestrogenic agent in late breast cancer: an early clinical appraisal ICI 46474;Cole;Br. J. Cancer,1971

4. Clinical trial of nafoxidine, an oestrogen antagonist in advanced breast cancer;Eortc Breast Cancer Group;Eur. J. Cancer,1972

5. Plasma hormones in patients with advanced breast cancer treated with tamoxifen;Colder;Eur. J. Cancer,1976

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. From Pure Antagonists to Pure Degraders of the Estrogen Receptor: Evolving Strategies for the Same Target;ACS Omega;2021-03-30

2. Continuous Exposure of Breast Cancer Cells to Tamoxifen Upregulates GPER-1 and Increases Cell Proliferation;Frontiers in Endocrinology;2020-09-30

3. Pure selective estrogen receptor modulators, new molecules having absolute cell specificity ranging from pure antiestrogenic to complete estrogen-like activities;Drug Discovery and Design;2001

4. EM-652 (SCH 57068), a third generation SERM acting as pure antiestrogen in the mammary gland and endometrium;The Journal of Steroid Biochemistry and Molecular Biology;1999-04

5. Acquisition of an Antiestrogen-Resistant Phenotype in Breast Cancer: Role of Cellular and Molecular Mechanisms;Drug Resistance;1996